RevealDX’s software analyses CT scans and assigns lung nodules with a Malignancy Similarity Index score to aid in lung cancer diagnosis.

Regulatory News: Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of ...

Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: ...

Median’s FDA clearance proceeds the FDA clearance of RevealDX’s comparable tool for lung nodule evaluation on 3 February. The ...

As of Thursday, February 12, Vontier Corporation’s VNT share price has surged by 17.04%, which has investors questioning if this is right time to sell.

The federal government said it's no longer going to pursue criminal charges for tampering with emissions equipment. But civil charges are still on the table. The U.S. Department of Justice has ordered ...

AI is becoming a strategic differentiator in industrial automation; those who learn to apply it effectively will shape the ...

Deepening sensorization expands diagnostic complexity across heavy-duty fleets, increasing demand for advanced, secure diagnostics.

Waters has announced the completion of its acquisition of BD’s Biosciences and Diagnostic Solutions businesses.

Dealers will be notified about the software concern by March 12, 2026, whereas customer notifications are to be mailed no later than March 26, 2026 ...

Federal prosecutors have quietly stepped back from one of the most aggressive fronts in the fight over automotive emissions, ordering criminal cases tied to on-board diagnostics tampering to be ...